Crosstalk between insulin and angiotensin II signalling systems

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 2, 1999, Pages 133-139

  Folli, F ^a,c   Saad, M J A ^b   Velloso, L ^b   Hansen, H ^c   Carandente, O ^d   Feener, E P ^c   Kahn, C R ^c  

^a Unit for Metabolic Diseases   (Italy)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Angiontensin II; Insulin; IRS 1; IRS 2; PI3 kinase; Serine phosphorylation

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; P13 KINASE; PHOSPHOTRANSFERASE; PROTEIN P85; PROTEIN SUBUNIT; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; BETA CHAIN; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; HEART; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; NONHUMAN; PHOSPHORYLATION AND DEPHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

EID: 0032932402     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212088     Document Type: Conference Paper

References (21)

1. Dhand R, Hiles I, Panatoyou G, Roche S, Fry MJ, Gout I, Totty NF, Troung O, Vicendo P, Yonezawa K: PI3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. Eur Mol Biol Organ J 13: 522-533, 1994
2. Dzau VJ,: Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens 12 (Suppl): S3-S10, 1994
3. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 317: 350-357, 1987
4. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP: Angiotensin II inhibits insulin signalling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/ angiotensin II crosstalk. J Clin Invest 100: 2158-2169, 1997
5. Folli F, Saad MJ, Backer JM, Kahn CR: Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem. 267: 22171-22171, 1992
6. Kelly KL, Ruderman NB: Insulin-stimulated phosphatidylinositol 3-kinase. J Biol Chem 268: 4391-4398, 1993
7. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes (Banting Lecture). Diabetes 43: 1066-1084, 1994
8. Linseman DA, Benjamin CW, Jones DA: Convergence of angiotensin II and platelet derived growth factor receptor signaling cascades in vascular smooth muscle. J Biol Chem 270: 12563-12568, 1995
9. 1 receptor. Nature 375: 247-250, 1995
10. Myers MG Jr, White MF: Insulin signal transduction and the IRS proteins. Annu Rev Pharmacol Toxicol 36: 615-658, 1996
11. Regitz-Zagrosek V, Neub M, Holzmeister J: Molecular biology of angiotensin receptors and their role in human cardiovascular disease. J Mol Med 74: 233-251, 1996
12. Rose DW, Saltiel AR, Majumdar M, Decker SJ, Olefsky JM: Insulin receptor substrate-1 is required for insulin mediated mitogenesis signal transduction. Proc Natl Acad Sci USA 91: 797-801, 1994
13. Saad MJA, Velloso LA, Carvalho CRO: Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem J 310: 741-744, 1996
14. Shieh S, Shen D, Sheu WHH, Fuh M, Jeng CY, Jeng JR, Chen YI, Reaven GM: Improvement in metabolic risks factors for coronary heart disease associated with cilazapril treatment. Am J Hypertens 5: 506-510, 1992
15. Takayama S, White MF, Kahn CR: Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 263: 3440-3447, 1988
16. Tanti J, Gremeaux T, Van Obberghen E, Le Marchand-Brustel Y: Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling: J Biol Chem 269: 6051-6057, 1994
17. Torlone E, Britta M, Rambotti AM, Periello G, Santeusanio F, Brunetti P, Bolli GB: Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes mellitus. Diabetes Care 16: 1347-1355, 1993
18. Velloso LA, Folli F, Sun XJ, White MF, Saad MJA, Kahn CR: Crosstalk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 93: 12490-12495, 1996
19. White MF, Kahn CR: The insulin signaling system. J Biol Chem 269: 1-4, 1994
20. White MF, Livingston JN, Backer JM, Lauris V, Dull TJ, Ullrich A, Kahn CR: Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not effect its tyrosine kinase activity. Cell 54: 641-649, 1988
21. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M: Risk factor for coronary artery disease in healthy persons with hyper-insulinaemia and normal glucose intolerance. N Engl J Med 320: 702-706, 1989